Williams W R, Davies B H
J Clin Lab Immunol. 1985 Mar;16(3):131-6.
Viable lymphocytes were used to investigate the binding of physiological concentrations of hormones and therapeutic concentrations of anti-asthmatic drugs to [3H]dihydroalprenolol (DHA, beta antagonist) and [3H]prazosin (alpha antagonist) receptor sites. All studied drugs and hormones inhibited the specific binding of prazosin to receptors identified with 10(-4)M phentolamine. Similar concentrations of drugs and hormones, with the exception of prostaglandin F2 alpha and cimetidine, inhibited the specific binding of DHA to lymphocyte receptors identified with 10(-7)M propranolol. These results confirm current mechanisms of hormone and drug action in asthma.
使用活淋巴细胞研究生理浓度的激素和治疗浓度的抗哮喘药物与[3H]二氢阿普洛尔(DHA,β拮抗剂)和[3H]哌唑嗪(α拮抗剂)受体位点的结合。所有研究的药物和激素均抑制哌唑嗪与用10(-4)M酚妥拉明鉴定的受体的特异性结合。除前列腺素F2α和西咪替丁外,相似浓度的药物和激素抑制DHA与用10(-7)M普萘洛尔鉴定的淋巴细胞受体的特异性结合。这些结果证实了目前激素和药物在哮喘中的作用机制。